COMPARISON OF CLINICAL EFFICACY AND SIDE EFFECTS OF LEVONORGESTREL IMPLANTS VERSUS COPPER T IUCD: A SIX-MONTH STUDY
DOI:
https://doi.org/10.55519/JAMC-01-14405Keywords:
Long-acting reversible contraception, Levonorgestrel implant. Copper intrauterine device, Contraceptive side effects, Menstrual irregularities, Contraceptive efficacy.Abstract
Background: This study examines long-term contraceptives, specifically comparing levonorgestrel implants and copper IUCDs, focusing on their effectiveness and side effects. The goal was to evaluate the performance and acceptance of Levonorgestrel implants versus copper IUCDs, documenting side effects for each method. Methods: Conducted at the Obstetrics & Gynecology Departments of PAF Hospital Islamabad and PAF Hospital, Kamra from December 2023 to May 2024. The study enrolled women opting for levonorgestrel implants or copper IUCDs. Out of an intended study sample of 166, 145 women aged 20-40 participated. Those using other contraceptives or with medical contraindications were excluded. Follow-ups over six months collected data on side effects and demographics, analyzed with SPSS-22, considering p s 0.05 significant. Results: Among 145 women, primarily 26-30 years old, those with lUCDs reported more prestudy menstrual irregularities (83.3%) than Levonorgestrel implant users (61.7%). Levonorgestrel implants resulted in fewer side effects like dysmenorrhea and headaches. Conclusion: Levonorgestrel implants and copper IUCDs are both effective at preventing pregnancy. Levonorgestrel implants, however, led to fewer side effects such as menstrual changes and weight gain, favoring its use. Both methods maintained high satisfaction after six months.
References
1. Lakha F, Glasier A. Unintended pregnancy and use of emergency contraception among a large cohort of women attending for antenatal care or abortion in Scotland. The Lancet. 2006 Nov 18; 368(9549):1782-7.
2. Trussell J, Aiken ARA, Micks E, Guthrie KA. Efficacy, safety, and personal considerations. In: Hatcher RA, Nelson AL, Trussell J, Cwiak C, Cason P, Policar MS, Edelman A, Aiken ARA, Marrazzo J, Kowal D, eds. Contraceptive technology. 21st ed. New York, NY: Ayer Company Publishers, Inc., 2018.
3. Harper CC, Rocca CH, Thompson KM, Morfesis J, Goodman S, Darney PD, et al.
Reductions in pregnancy rates in the USA with long-acting reversible contraception: A cluster randomised trial. The Lancet. 2015 Aug 8; 386(9993):562-8.
4. Espey E, Hofler L. Practice Bulletin No. 186: LongActing reversible contraception:
Implants and intrauterine devices. Obstetrics and gynecology. 2017; 130(5):E251- 69. Available from: https://pubmed.ncbi.nlm.nih. gov/29064972/
5. UKMEC April 2016 (Amended September 2019)- Faculty of sexual and reproductive healthcare. Available from: https:// www.fsrh.org/standards-and-guidance/documents/ ukmec-2016/
6. Gao J, Wang S Ii, Wu S chun, Sun 8 ling, Allonen H, Luukkainen T. Comparison of the clinical performance, contraceptive efficacy and acceptability of levonorgestrel-releasing IUD and NorplantR-2 implants in China. Contraception. 1990; 41(5):485-94.
7. FSRH Clinical Guideline: Intrauterine Contraception (April 2015, amended September 2019) - Faculty of Sexual and Reproductive Healthcare. Available from: https://www. fsrh.org/standards-and-guidance/documents/ ceuguidanceintrauterinecontraception/
8. Smith GCS, Pell JP, Dobbie R. lnterpregnancy interval and risk of preterm birth and neonatal death: Retrospective cohort study. BMJ. 2003; 327(7410):313. Available from: https://www.bmj.com/content/327 /7 410/313
9. Trussell J. Contraceptive efficacy. The global library of women's medicine. 2014; Available from: http://www.glowm.com/seclionview/headinq/Contracept.ive Efficacy/item/374
10. 15. Kavanaugh ML, Pliskin E. Use of contraception among reproductive-aged women in the United States. 2014 and 2016. F S Rep. 2020 Sep 1; 1(2):83-93.
11. Health BHN for women's, 2017 undefined. Barriers to health care providers' provision of long-acting reversible contraception to adolescent and nulliparous young women. Elsevier; Available from: https://www.sciencedirect. com/science/article/pii/S 1751485117300533
12. Enyindah C, Medicine TKNJ of, 2011 undefined. Jadelle® Subdennal Implants. Pr eliminary experience in a teaching hospital in the Niger delta region of Nigeria. ajol.info. 2016; 33(1). Available from: https://www.ajol.info/index.php/ njm/article/view/91598/8107 4
13. Tariq A, Raja A, Khan SR, Jawad N, Malik TM, Malik MT. long-acting reversible contraceptives - Implant vs. Intrauterine Device; Why go for either? Professional Med J 2023; 30(01):51-57.
14. Pam VC, Mutihir JT, Nyango DD, Shambe I, Egbodo CO, Karshima JA. Sociodemographic profiles and use-dynamics of Jadelle (levonorgestrel) implants in Jos. Nigeria. Niger Med J. 2016; 57(6):314. Available from: /pmc/articles/ PMC5126742/
15. Menon S. long-acting reversible contraception: Specific issues for adolescents. Pediatrics. 2020 Aug 1; 146(2). Available from: /pediatrics/artide/146/2/e2020007252/36888/LongActing-Reversible-Contraception¬Specific
16. Rocca ML, Palumbo AR, Visconti F, di Cano C. Safety and benefits of contraceptives implants: A systematic review. Pharmaceuticals 2021, Vol 14, Page 548. 2021 Jun 8; 14(6):548. Available from: https://www.mdpi.com/1424- 8247/14/6/548/htm
17. Matos JE, Balkaran BL, Rooney J, Crespi S. Preference for contraceptive implant among women 18-44 years old. https://home.liebertpub.corn/whr. 2021 Dec 15; 2(1):622-32. Available from: https://www.liebertpub.com/doi/10.1089/whr.2021.0113
18. Paul, Huysman BC, Maddipati R, Madden T. Familiarity and acceptability of long¬acting reversible contraception and contraceptive choice. Am J Obstet Gynecol. 2020 Apr 1; 222(4):S884.e1-S884.e9.
19. Birgisson NE, Zhao Q, Secura GM, Madden T, Peipert JF. Preventing unintended pregnancy: The contraceptive CHOICE project in review. J Womens Health. 2015 May 1; 24(5):349-53.
20. Tsikouras P, Deuteraiou D, Bothou A. Anthoulaki X, Chalkidou A, Chatzimichael E, et al. Ten years of experience in contraception options for teenagers in a family planning center in Thrace and review of the literature. International Journal of Environmental Research and Public Health 2018, Vol 15, Page 348. 2018 Feb 15; 15(2):348. Available from: https://www.mdpi.com/1660- 4601/15/2/348/htm
21. Siddiqui M, Fatima K, Ali SN, Fatima M, Naveed W, Siddiqui F, et al. Prevalence and predictors of contraception usage in Karachi, Pakistan. Cureus. 2020 Oct 30; 12(10). Available from: https://www.cureus.com/articles/40271- prevalence-and-predictors-of-contraception-usage-inkarachi-pakistan
22. Shamim N, Rehan N, (Internet} AIJPMA, 1994 undefined. Use of Norplant in Pakistan: Two years experience. jpma.org.pk. 2014; Available from: https://www.jpma.org.pk/ PdfDownload/4699
23. Jacobstein R. liftoff: The blossoming of contraceptive implant use in Africa. Glob Health Sci Pract. 2018 Mar 21; 6(1):17-39. Available from: https://www.ghspjoumal.org/content/6/1 /17
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Amina Akbar, Adila Anwar, Shakra Tabasam, Sadaf Afroze, Ghana Shahid, Shehnaz Sheeba
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
